Glycemic Variability in Intermittent Fasting (NCT05806489) | Clinical Trial Compass
CompletedNot Applicable
Glycemic Variability in Intermittent Fasting
Croatia10 participantsStarted 2021-01-26
Plain-language summary
The aim was to test the difference in glycemic variability after meal consumption during intermittent fasting and the usual diet.
Who can participate
Age range20 Years – 45 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Body Mass Index in the range between 18.5 and 29.9 kg/m\^2
* stable sleep pattern (going to bed between 21:30h and midnight)
* for women: regular menstrual cycle lasting between 21 and 35 days, with average bleeding time 2 to 6 days
Exclusion Criteria:
* Body Mass Index below 18.5 or above 29.9 kg/m\^2
* irregular sleeping pattern
* work in nightshift
* high intensity workout routine
* irregular dietary patterns (e.g. skipping meals)
* regularly fasting for more than 15 hours per day
* diagnosis of diabetes (or other conditions related to glycemic disorders)
* hypertension or other cardiovascular disease
* neurologic conditions
* disease affecting metabolism (like liver, kidney, thyroid or lung)
* use of medications for glycemia, hypertension, steroids, adrenergic stimulators, laxatives or supplements affecting glycemia, circadian rhythm, sleep or metabolism in general
What they're measuring
1
Blood glucose
Timeframe: 3 days per protocol
2
Glycemic variability
Timeframe: 3 days per protocol
Trial details
NCT IDNCT05806489
SponsorJosip Juraj Strossmayer University of Osijek